In reply to @polybiorf

PolyBio

PolyBio

@polybiorf · Twitter ·

Notably, MENSA is being tested for its ability to identify responders to repurposed antiviral medications within Long COVID clinical trials at Mount Sinai’s CoRE clinic in New York City. 6/ Study background: https://polybio.org/projects/a-clinical-trial-of-repurposed-hiv-antivirals-in-longcovid/

An image of a medication bottle in red with a white cap and a white cross on the front. The top of the bottle points outward with arrows to three viruses. The study title reads “Repurposing HIV Antivirals for Long COVID.”